Reduced angiopoietin-2 as a predictive biomarker for clomiphene citrate resistance in polycystic ovary syndrome

Background: Even though angiopoeitin-2 and interleukin (IL)-23 are known to be altered in polycystic ovary syndrome (PCOS), their association with clomiphene citrate (CC) resistance has not been studied. Aim: The objective of the study was to investigate whether angiopoietin-2 levels are associated...

Full description

Bibliographic Details
Main Authors: Luxmipratha Rajendiran, Hanumanthappa Nandeesha, Thyagaraju Chitra
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Journal of Human Reproductive Sciences
Subjects:
Online Access:http://www.jhrsonline.org/article.asp?issn=0974-1208;year=2021;volume=14;issue=2;spage=144;epage=148;aulast=Rajendiran
_version_ 1818864781477543936
author Luxmipratha Rajendiran
Hanumanthappa Nandeesha
Thyagaraju Chitra
author_facet Luxmipratha Rajendiran
Hanumanthappa Nandeesha
Thyagaraju Chitra
author_sort Luxmipratha Rajendiran
collection DOAJ
description Background: Even though angiopoeitin-2 and interleukin (IL)-23 are known to be altered in polycystic ovary syndrome (PCOS), their association with clomiphene citrate (CC) resistance has not been studied. Aim: The objective of the study was to investigate whether angiopoietin-2 levels are associated with inflammation and CC resistance in PCOS. Settings and Design: This study was conducted in a tertiary care hospital. Materials and Methods: Eighty-one women diagnosed with PCOS and on treatment with CC were enrolled in the study. Angiopoeitin-2 and IL -23 were analyzed in all the subjects. Results: Angiopoietin-2 was significantly reduced (P = 0.018), and body mass index (BMI) (P = 0.049) and duration of infertility (0.006) were significantly increased in PCOS women with CC resistance compared to those who are sensitive to CC. In CC resistant PCOS, IL-23 predicts reduction in angiopoietin-2 levels (P = 0.010). Among angiopoietin-2, IL-23, BMI, and duration of infertility, we found that angiopoeitn-2 (P = 0.020) and duration of infertility (0.036) can predict resistance to CC therapy among PCOS subjects. Conclusion: We conclude that reduced angiopoietin-2 levels predict CC resistance in women with PCOS.
first_indexed 2024-12-19T10:37:07Z
format Article
id doaj.art-618a6c10e36847a1adb218c2766772e1
institution Directory Open Access Journal
issn 0974-1208
1998-4766
language English
last_indexed 2024-12-19T10:37:07Z
publishDate 2021-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Human Reproductive Sciences
spelling doaj.art-618a6c10e36847a1adb218c2766772e12022-12-21T20:25:34ZengWolters Kluwer Medknow PublicationsJournal of Human Reproductive Sciences0974-12081998-47662021-01-0114214414810.4103/jhrs.jhrs_179_20Reduced angiopoietin-2 as a predictive biomarker for clomiphene citrate resistance in polycystic ovary syndromeLuxmipratha RajendiranHanumanthappa NandeeshaThyagaraju ChitraBackground: Even though angiopoeitin-2 and interleukin (IL)-23 are known to be altered in polycystic ovary syndrome (PCOS), their association with clomiphene citrate (CC) resistance has not been studied. Aim: The objective of the study was to investigate whether angiopoietin-2 levels are associated with inflammation and CC resistance in PCOS. Settings and Design: This study was conducted in a tertiary care hospital. Materials and Methods: Eighty-one women diagnosed with PCOS and on treatment with CC were enrolled in the study. Angiopoeitin-2 and IL -23 were analyzed in all the subjects. Results: Angiopoietin-2 was significantly reduced (P = 0.018), and body mass index (BMI) (P = 0.049) and duration of infertility (0.006) were significantly increased in PCOS women with CC resistance compared to those who are sensitive to CC. In CC resistant PCOS, IL-23 predicts reduction in angiopoietin-2 levels (P = 0.010). Among angiopoietin-2, IL-23, BMI, and duration of infertility, we found that angiopoeitn-2 (P = 0.020) and duration of infertility (0.036) can predict resistance to CC therapy among PCOS subjects. Conclusion: We conclude that reduced angiopoietin-2 levels predict CC resistance in women with PCOS.http://www.jhrsonline.org/article.asp?issn=0974-1208;year=2021;volume=14;issue=2;spage=144;epage=148;aulast=Rajendiranangiopoietinsclomiphene citrateinterleukinspolycystic ovary syndrome
spellingShingle Luxmipratha Rajendiran
Hanumanthappa Nandeesha
Thyagaraju Chitra
Reduced angiopoietin-2 as a predictive biomarker for clomiphene citrate resistance in polycystic ovary syndrome
Journal of Human Reproductive Sciences
angiopoietins
clomiphene citrate
interleukins
polycystic ovary syndrome
title Reduced angiopoietin-2 as a predictive biomarker for clomiphene citrate resistance in polycystic ovary syndrome
title_full Reduced angiopoietin-2 as a predictive biomarker for clomiphene citrate resistance in polycystic ovary syndrome
title_fullStr Reduced angiopoietin-2 as a predictive biomarker for clomiphene citrate resistance in polycystic ovary syndrome
title_full_unstemmed Reduced angiopoietin-2 as a predictive biomarker for clomiphene citrate resistance in polycystic ovary syndrome
title_short Reduced angiopoietin-2 as a predictive biomarker for clomiphene citrate resistance in polycystic ovary syndrome
title_sort reduced angiopoietin 2 as a predictive biomarker for clomiphene citrate resistance in polycystic ovary syndrome
topic angiopoietins
clomiphene citrate
interleukins
polycystic ovary syndrome
url http://www.jhrsonline.org/article.asp?issn=0974-1208;year=2021;volume=14;issue=2;spage=144;epage=148;aulast=Rajendiran
work_keys_str_mv AT luxmipratharajendiran reducedangiopoietin2asapredictivebiomarkerforclomiphenecitrateresistanceinpolycysticovarysyndrome
AT hanumanthappanandeesha reducedangiopoietin2asapredictivebiomarkerforclomiphenecitrateresistanceinpolycysticovarysyndrome
AT thyagarajuchitra reducedangiopoietin2asapredictivebiomarkerforclomiphenecitrateresistanceinpolycysticovarysyndrome